Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

Navarro-Triviño FJ, Torres T, Ruiz-Villaverde R, Moreno-Amador JL, Mendes-Bastos P

Open source

DOI
10.1007/s12016-026-09188-w
Published
2026 Aug 4
Container
Clinical reviews in allergy & immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12016-026-09188-w,
  title = {Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.},
  author = {Navarro-Triviño FJ and Torres T and Ruiz-Villaverde R and Moreno-Amador JL and Mendes-Bastos P},
  year = {2026},
  journal = {Clinical reviews in allergy \& immunology},
  doi = {10.1007/s12016-026-09188-w},
  url = {https://doi.org/10.1007/s12016-026-09188-w}
}

RIS

TY  - JOUR
TI  - Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.
AU  - Navarro-Triviño FJ
AU  - Torres T
AU  - Ruiz-Villaverde R
AU  - Moreno-Amador JL
AU  - Mendes-Bastos P
PY  - 2026
JO  - Clinical reviews in allergy & immunology
DO  - 10.1007/s12016-026-09188-w
UR  - https://doi.org/10.1007/s12016-026-09188-w
ER  - 

APA

FJ, N., T, T., R, R., JL, M., & P, M. (2026). Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.. Clinical reviews in allergy & immunology. https://doi.org/10.1007/s12016-026-09188-w

Source records